These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 27865284)

  • 1. Management of Metastatic Pancreatic Adenocarcinoma.
    Cheema AR; O'Reilly EM
    Surg Clin North Am; 2016 Dec; 96(6):1391-1414. PubMed ID: 27865284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic ductal adenocarcinoma: State-of-the-art 2017 and new therapeutic strategies.
    Chiaravalli M; Reni M; O'Reilly EM
    Cancer Treat Rev; 2017 Nov; 60():32-43. PubMed ID: 28869888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Management of localized, locally advanced and metastatic pancreatic adenocarcinoma].
    Delpero JR; Turrini O; Raoul JL
    Rev Prat; 2015 Mar; 65(3):382-9. PubMed ID: 26016202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advancements in the management of pancreatic cancer: 2013.
    Saif MW
    JOP; 2013 Mar; 14(2):112-8. PubMed ID: 23474549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic pancreatic ductal adenocarcinoma: diagnosis and treatment with a view to the future.
    Pokorny AMJ; Chin VT; Nagrial AM; Yip D; Chantrill LA
    Intern Med J; 2018 Jun; 48(6):637-644. PubMed ID: 29898269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of unresectable, locally advanced pancreatic adenocarcinoma.
    Salgado M; Arévalo S; Hernando O; Martínez A; Yaya R; Hidalgo M
    Clin Transl Oncol; 2018 Feb; 20(2):113-118. PubMed ID: 28612202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of metastatic pancreatic cancer: Current treatment options and potential new therapeutic targets.
    Sclafani F; Iyer R; Cunningham D; Starling N
    Crit Rev Oncol Hematol; 2015 Sep; 95(3):318-36. PubMed ID: 25921418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe hyponatremia caused by nab-paclitaxel-induced syndrome of inappropriate antidiuretic hormone secretion: A case report in a patient with metastatic pancreatic adenocarcinoma.
    Neuzillet C; Babai S; Kempf E; Pujol G; Rousseau B; Le-Louët H; Christophe Tournigand
    Medicine (Baltimore); 2016 Jun; 95(26):e4006. PubMed ID: 27368013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perspectives in the treatment of pancreatic adenocarcinoma.
    Cid-Arregui A; Juarez V
    World J Gastroenterol; 2015 Aug; 21(31):9297-316. PubMed ID: 26309356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic Approaches for Metastatic Pancreatic Adenocarcinoma.
    Rubinson DA; Wolpin BM
    Hematol Oncol Clin North Am; 2015 Aug; 29(4):761-76. PubMed ID: 26226909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. State of the art and future directions of pancreatic ductal adenocarcinoma therapy.
    Neuzillet C; Tijeras-Raballand A; Bourget P; Cros J; Couvelard A; Sauvanet A; Vullierme MP; Tournigand C; Hammel P
    Pharmacol Ther; 2015 Nov; 155():80-104. PubMed ID: 26299994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: a retrospective study.
    Gbolahan OB; Tong Y; Sehdev A; O'Neil B; Shahda S
    BMC Cancer; 2019 May; 19(1):468. PubMed ID: 31101022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Pancreatic Adenocarcinoma in Elderly Patients over 75 Years of Age: A Retrospective Series of 129 Patients.
    Oziel-Taieb S; Faure M; Gilabert M; Autret A; Turrini O; Moureau-Zabotto L; Giovannini M; Rousseau F; Raoul JL
    J Gastrointest Cancer; 2016 Mar; 47(1):15-9. PubMed ID: 26545612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
    Tempero MA; Malafa MP; Al-Hawary M; Asbun H; Bain A; Behrman SW; Benson AB; Binder E; Cardin DB; Cha C; Chiorean EG; Chung V; Czito B; Dillhoff M; Dotan E; Ferrone CR; Hardacre J; Hawkins WG; Herman J; Ko AH; Komanduri S; Koong A; LoConte N; Lowy AM; Moravek C; Nakakura EK; O'Reilly EM; Obando J; Reddy S; Scaife C; Thayer S; Weekes CD; Wolff RA; Wolpin BM; Burns J; Darlow S
    J Natl Compr Canc Netw; 2017 Aug; 15(8):1028-1061. PubMed ID: 28784865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and Evolving Therapies for Metastatic Pancreatic Cancer: Are We Stuck With Cytotoxic Chemotherapy?
    Varadhachary GR; Wolff RA
    J Oncol Pract; 2016 Sep; 12(9):797-805. PubMed ID: 27621332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of pancreatic cancer. Actuality and perspective].
    Bittoni A; Andrikou K; Lanese A; Santoni M; Pellei C; Faloppi L; Del Prete M; Giampieri R; Cascinu S
    Recenti Prog Med; 2015 May; 106(5):208-16. PubMed ID: 25994537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Advances in the Treatment of Metastatic Pancreatic Cancer.
    Schober M; Javed MA; Beyer G; Le N; Vinci A; Sund M; Neesse A; Krug S
    Digestion; 2015; 92(3):175-84. PubMed ID: 26372949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced-stage pancreatic cancer: therapy options.
    Werner J; Combs SE; Springfeld C; Hartwig W; Hackert T; Büchler MW
    Nat Rev Clin Oncol; 2013 Jun; 10(6):323-33. PubMed ID: 23629472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smarter drugs emerging in pancreatic cancer therapy.
    Kleger A; Perkhofer L; Seufferlein T
    Ann Oncol; 2014 Jul; 25(7):1260-1270. PubMed ID: 24631947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges and future directions in therapeutics for pancreatic ductal adenocarcinoma.
    Al Haddad AH; Adrian TE
    Expert Opin Investig Drugs; 2014 Nov; 23(11):1499-515. PubMed ID: 25078674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.